Varsha Didolkar

Statistics

Publications

Citations

225

H-Index

Active since

1998

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Varsha Didolkar is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, drug disposition, and pharmacokinetics.

Publications per year

1998–2008

Publications

Sex Hormone-Binding Globulin Mediates Prostate Androgen Receptor Action via a Novel Signaling Pathway

Victor Ding, David E. Moller, William P. Feeney et al. · Endocrinology · 1998 · 69 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

EVIDENCE FOR THE BIOACTIVATION OF ZOMEPIRAC AND TOLMETIN BY AN OXIDATIVE PATHWAY: IDENTIFICATION OF GLUTATHIONE ADDUCTS IN VITRO IN HUMAN LIVER MICROSOMES AND IN VIVO IN RATS

Qing Chen, George A. Doss, Elaine Tung et al. · Drug Metabolism and Disposition · 2005 · 58 citations

Pharmacy, Pharmacology, Toxicology +17

Assessment of the CYP3A‐Mediated Drug Interaction Potential of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Volunteers

Rajesh Krishna, Arthur Bergman, Bo Jin et al. · The Journal of Clinical Pharmacology · 2008 · 38 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Integrating qualitative and quantitative liquid chromatography/tandem mass spectrometric analysis to support drug discovery

Grace K. Poon, Gloria Y. Kwei, R. Wang et al. · Rapid Communications in Mass Spectrometry · 1999 · 35 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Pharmacokinetics and Interactions of a Novel Antagonist of Chemokine Receptor 5 (CCR5) with Ritonavir in Rats and Monkeys: Role of CYP3A and P-Glycoprotein

Sanjeev Kumar, Gloria Y. Kwei, Grace K. Poon et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 25 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

1–5 of 5